Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 2.70 is 98% below its estimated 5-year average of 121.40, near the low end of its estimated 5-year range (0.89–1191.73).
As of 2026-10-06T13:36:31.818Z. 27.29% above its estimated 12-month average of 2.12.
Calculation as of: 2026-10-06T13:36:31.818Z.
Quote observation: 2026-10-06T13:33:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4936500bc1589ca9a686c77de910b68cd28581e4c5f82a550ef1f7d6df46dce9
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
2.70
PS RATIO AVG TTM
2.12
PS RATIO AVG 3Y
1.98
PS RATIO AVG 5Y
121.40
PS RATIO AVG 10Y
220.66
PS RATIO AVG 15Y
170.85
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+27.29%
CURRENT VS 3Y AVG
+36.11%
CURRENT VS 5Y AVG
-97.78%
CURRENT VS 10Y AVG
-98.78%
CURRENT VS 15Y AVG
-98.42%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.02
median of 359 covered companies
CURRENT VS SECTOR MEDIAN
-32.84%
vs the sector median at left
Market Cap
$3.42M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.13M
PS Ratio
N/A
TTM Avg
71.18
3Y Avg
73.71
5Y Avg
73.71
Market Cap
$3.04M
PS Ratio
8.49
TTM Avg
15.52
3Y Avg
50.28
5Y Avg
84.84
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evogene Ltd. (EVGN) | $3.53M | 2.70 | 2.12 | 1.98 | 121.40 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | N/A | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.38M | 0.86 | 8.88 | 13.52 | 16.08 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.31M | N/A | 69.25 | 700.44 | 2108.35 |
| Eocene Ltd. (EOCN)vs › | $3.78M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | N/A | 71.18 | 73.71 | 73.71 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | 8.49 | 15.52 | 50.28 | 84.84 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.13M | N/A | 1.94 | 5.55 | 4.76 |
| Jaguar Health, Inc. (JAGX)vs › | $2.74M | 0.10 | 0.09 | 0.25 | 0.61 |
| GRI Bio, Inc. (GRI)vs › | $4.36M | N/A | 66865.41 | 66865.41 | 66865.41 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $312,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20 |
| Q4 FY2025Period ended 2025-12-31 | $314,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $334,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-20 |
| Q2 FY2026Period ended 2026-06-30 | $347,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-28 |
| TTM revenue | $1,307,000 |
Current P/S: $3,531,174 market capitalization ÷ $1,307,000 TTM revenue = 2.70x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:33:38.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 2.70, P/S is at an extreme level, where the multiple carries little signal — higher than 15% of readings in its estimated 14-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 14-year low
0.89
median
200.07
estimated 14-year high
3331.10
P/S Ratio
2.70
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 3.77 |
| 2026-10-02 | 3.97 |
| 2026-10-01 | 4.07 |
| 2026-09-30 | 3.71 |
| 2026-09-29 | 3.83 |
| 2026-09-28 | 2.01 |
| 2026-09-25 | 2.20 |
| 2026-09-24 | 2.24 |
| 2026-09-23 | 2.39 |
| 2026-09-22 | 2.61 |
| 2026-09-21 | 2.45 |
| 2026-09-18 | 2.64 |
| 2026-09-17 | 2.66 |
| 2026-09-16 | 2.62 |
| 2026-09-15 | 2.79 |
| 2026-09-14 | 2.61 |
| 2026-09-11 | 2.54 |
| 2026-09-10 | 2.54 |
| 2026-09-09 | 2.65 |
| 2026-09-08 | 2.68 |
| 2026-09-04 | 2.84 |
| 2026-09-03 | 2.88 |
| 2026-09-02 | 2.85 |
| 2026-09-01 | 2.75 |
| 2026-08-31 | 2.83 |
| 2026-08-28 | 2.90 |
| 2026-08-27 | 2.84 |
| 2026-08-26 | 2.87 |
| 2026-08-25 | 2.90 |
| 2026-08-24 | 2.95 |
| 2026-08-21 | 2.97 |
| 2026-08-20 | 2.96 |
| 2026-08-19 | 3.17 |
| 2026-08-18 | 3.08 |
| 2026-08-17 | 2.96 |
| 2026-08-14 | 3.17 |
| 2026-08-13 | 3.44 |
| 2026-08-12 | 3.23 |
| 2026-08-11 | 3.70 |
| 2026-08-10 | 3.34 |
| 2026-08-07 | 3.17 |
| 2026-08-06 | 3.62 |
| 2026-08-05 | 3.33 |
| 2026-08-04 | 3.43 |
| 2026-08-03 | 2.83 |
| 2026-07-31 | 2.49 |
| 2026-07-30 | 2.58 |
| 2026-07-29 | 2.54 |
| 2026-07-28 | 2.61 |
| 2026-07-27 | 2.75 |
| 2026-07-24 | 2.87 |
| 2026-07-23 | 2.87 |
| 2026-07-22 | 2.88 |
| 2026-07-21 | 2.81 |
| 2026-07-20 | 2.90 |
| 2026-07-17 | 3.32 |
| 2026-07-16 | 3.09 |
| 2026-07-15 | 3.06 |
| 2026-07-14 | 2.55 |
| 2026-07-13 | 2.45 |
| 2026-07-10 | 2.70 |
| 2026-07-09 | 2.64 |
| 2026-07-08 | 2.19 |
| 2026-07-07 | 2.24 |
| 2026-07-06 | 2.31 |
| 2026-07-02 | 2.27 |
| 2026-07-01 | 2.33 |
| 2026-06-30 | 2.32 |
| 2026-06-29 | 2.28 |
| 2026-06-26 | 2.05 |
| 2026-06-25 | 2.10 |
| 2026-06-24 | 2.32 |
| 2026-06-23 | 2.59 |
| 2026-06-22 | 2.64 |
| 2026-06-18 | 2.77 |
| 2026-06-17 | 2.93 |
| 2026-06-16 | 2.96 |
| 2026-06-15 | 3.07 |
| 2026-06-12 | 3.08 |
| 2026-06-11 | 3.12 |
| 2026-06-10 | 3.13 |
| 2026-06-09 | 3.15 |
| 2026-06-08 | 3.08 |
| 2026-06-05 | 3.27 |
| 2026-06-04 | 3.22 |
| 2026-06-03 | 3.16 |
| 2026-06-02 | 3.12 |
| 2026-06-01 | 3.61 |
| 2026-05-29 | 3.72 |
| 2026-05-28 | 3.78 |
| 2026-05-27 | 3.75 |
| 2026-05-26 | 3.74 |
| 2026-05-22 | 3.70 |
| 2026-05-21 | 3.66 |
| 2026-05-20 | 1.59 |
| 2026-05-19 | 1.64 |
| 2026-05-18 | 1.54 |
| 2026-05-15 | 1.61 |
| 2026-05-14 | 1.64 |
| 2026-05-13 | 1.68 |
| 2026-05-12 | 1.68 |
| 2026-05-11 | 1.71 |
| 2026-05-08 | 1.66 |
| 2026-05-07 | 1.72 |
| 2026-05-06 | 1.74 |
| 2026-05-05 | 1.70 |
| 2026-05-04 | 1.66 |
| 2026-05-01 | 1.69 |
| 2026-04-30 | 1.72 |
| 2026-04-29 | 1.67 |
| 2026-04-28 | 1.73 |
| 2026-04-27 | 1.72 |
| 2026-04-24 | 1.74 |
| 2026-04-23 | 1.73 |
| 2026-04-22 | 1.79 |
| 2026-04-21 | 1.76 |
| 2026-04-20 | 1.76 |
| 2026-04-17 | 1.77 |
| 2026-04-16 | 1.75 |
| 2026-04-15 | 1.88 |
| 2026-04-14 | 1.81 |
| 2026-04-13 | 1.81 |
| 2026-04-10 | 1.79 |
| 2026-04-09 | 1.81 |
| 2026-04-08 | 1.77 |
| 2026-04-07 | 1.81 |
| 2026-04-06 | 1.72 |
| 2026-04-02 | 1.73 |
| 2026-04-01 | 1.78 |
| 2026-03-31 | 1.70 |
| 2026-03-30 | 1.62 |
| 2026-03-27 | 1.80 |
| 2026-03-26 | 1.81 |
| 2026-03-25 | 1.87 |
| 2026-03-24 | 1.95 |
| 2026-03-23 | 2.06 |
| 2026-03-20 | 1.87 |
| 2026-03-19 | 1.87 |
| 2026-03-18 | 1.87 |
| 2026-03-17 | 1.92 |
| 2026-03-16 | 1.74 |
| 2026-03-13 | 1.76 |
| 2026-03-12 | 1.78 |
| 2026-03-11 | 1.66 |
| 2026-03-10 | 1.74 |
| 2026-03-09 | 1.69 |
| 2026-03-06 | 1.69 |
| 2026-03-05 | 1.31 |
| 2026-03-04 | 1.39 |
| 2026-03-03 | 1.41 |
| 2026-03-02 | 1.43 |
| 2026-02-27 | 1.46 |
| 2026-02-26 | 1.43 |
| 2026-02-25 | 1.46 |
| 2026-02-24 | 1.39 |
| 2026-02-23 | 1.35 |
| 2026-02-20 | 1.36 |
| 2026-02-19 | 1.47 |
| 2026-02-18 | 1.56 |
| 2026-02-17 | 1.62 |
| 2026-02-13 | 1.59 |
| 2026-02-12 | 1.57 |
| 2026-02-11 | 1.69 |
| 2026-02-10 | 1.68 |
| 2026-02-09 | 1.81 |
| 2026-02-06 | 1.79 |
| 2026-02-05 | 1.83 |
| 2026-02-04 | 1.81 |
| 2026-02-03 | 1.73 |
| 2026-02-02 | 1.69 |
| 2026-01-30 | 1.68 |
| 2026-01-29 | 1.68 |
| 2026-01-28 | 1.76 |
| 2026-01-27 | 1.79 |
| 2026-01-26 | 1.76 |
| 2026-01-23 | 1.76 |
| 2026-01-22 | 1.71 |
| 2026-01-21 | 1.69 |
| 2026-01-20 | 1.68 |
| 2026-01-16 | 1.74 |
| 2026-01-15 | 1.74 |
| 2026-01-14 | 1.74 |
| 2026-01-13 | 1.71 |
| 2026-01-12 | 1.79 |
| 2026-01-09 | 1.84 |
| 2026-01-08 | 1.84 |
| 2026-01-07 | 1.89 |
| 2026-01-06 | 1.91 |
| 2026-01-05 | 1.86 |
| 2026-01-02 | 1.88 |
| 2025-12-31 | 1.83 |
| 2025-12-30 | 1.56 |
| 2025-12-29 | 1.61 |
| 2025-12-26 | 1.71 |
| 2025-12-24 | 1.74 |
| 2025-12-23 | 1.74 |
| 2025-12-22 | 1.71 |
| 2025-12-19 | 1.69 |
| 2025-12-18 | 1.64 |
| 2025-12-17 | 1.68 |
| 2025-12-16 | 1.74 |
| 2025-12-15 | 1.74 |
| 2025-12-12 | 1.79 |
| 2025-12-11 | 1.81 |
| 2025-12-10 | 1.83 |
| 2025-12-09 | 1.81 |
| 2025-12-08 | 1.91 |
| 2025-12-05 | 1.84 |
| 2025-12-04 | 1.83 |
| 2025-12-03 | 1.76 |
| 2025-12-02 | 1.76 |
| 2025-12-01 | 1.71 |
| 2025-11-28 | 1.76 |
| 2025-11-26 | 1.89 |
| 2025-11-25 | 1.83 |
| 2025-11-24 | 1.91 |
| 2025-11-21 | 1.88 |
| 2025-11-20 | 1.17 |
| 2025-11-19 | 1.27 |
| 2025-11-18 | 1.27 |
| 2025-11-17 | 1.30 |
| 2025-11-14 | 1.31 |
| 2025-11-13 | 1.29 |
| 2025-11-12 | 1.35 |
| 2025-11-11 | 1.34 |
| 2025-11-10 | 1.29 |
| 2025-11-07 | 1.24 |
| 2025-11-06 | 1.25 |
| 2025-11-05 | 1.28 |
| 2025-11-04 | 1.32 |
| 2025-11-03 | 1.36 |
| 2025-10-31 | 1.36 |
| 2025-10-30 | 1.33 |
| 2025-10-29 | 1.38 |
| 2025-10-28 | 1.42 |
| 2025-10-27 | 1.37 |
| 2025-10-24 | 1.35 |
| 2025-10-23 | 1.34 |
| 2025-10-22 | 1.37 |
| 2025-10-21 | 1.41 |
| 2025-10-20 | 1.36 |
| 2025-10-17 | 1.35 |
| 2025-10-16 | 1.38 |
| 2025-10-15 | 1.49 |
| 2025-10-14 | 1.41 |
| 2025-10-13 | 1.38 |
| 2025-10-10 | 1.40 |
| 2025-10-09 | 1.45 |
| 2025-10-08 | 1.58 |
| 2025-10-07 | 1.44 |
| 2025-10-06 | 1.35 |
| 2025-10-03 | 1.24 |
| 2025-10-02 | 1.21 |
| 2025-10-01 | 1.24 |
| 2025-09-30 | 1.21 |
| 2025-09-29 | 1.25 |
| 2025-09-26 | 1.21 |
| 2025-09-25 | 1.18 |
| 2025-09-24 | 1.24 |
| 2025-09-23 | 1.24 |
Showing the most recent 260 of 3,192 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
